BIOMAT Database Logo BIOMAT Database Logo

Effects of glutathione depletion using buthionine sulphoximine on the cytotoxicity in mammalian cells and human tumor cells in vitro. 1992

Y Z Jin, and L Ding, and Z F Shen, and R M Cai, and L M Xu, and J K Yang, and X Q Jin, and W Q Lu, and J F Xu
Institute of Radiation Medicine, Shanghai Medical University.

An inhibitor of glutathione biosynthesis, buthionine sulphoximine (BSO), was used to deplete the endogenous thiols in mammalian cells in vitro. In this study, the cytotoxicity of BSO and BSO combined with the hypoxic cell radiosensitizer misonidazole (MISO) was investigated. Both aerobic and hypoxic cytotoxicity of MISO was found to be increased. The concentration of BSO required to reduce the colony forming ability to 50% (Cc) for the chronic cytotoxicity on V79 cells was 0.03 mmol/L under aerobic condition, while the Cc for the acute cytotoxicity on V79 cells under hypoxic and aerobic conditions was 0.4 and 0.5 mmol/L. The growth inhibition rate of human tumor cells K562 and SGC-7901 by BSO was 6.89-26.06% and 12.01-55.69%, respectively. Enhanced cytotoxicity activity was observed when BSO was used in combination with cis-dichlorodiamino Pt(II) or 5-fluorouracil.

UI MeSH Term Description Entries
D008717 Methionine Sulfoximine Sulfoximine, Methionine
D008920 Misonidazole A nitroimidazole that sensitizes normally radio-resistant hypoxic cells to radiation. It may also be directly cytotoxic to hypoxic cells and has been proposed as an antineoplastic. Ro 07-0582,Ro 7-0582,alpha-(Methoxymethyl)-2-nitro-1H-imidazole-1-ethanol,Ro 07 0582,Ro 070582,Ro 7 0582,Ro 70582
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D004915 Leukemia, Erythroblastic, Acute A myeloproliferative disorder characterized by neoplastic proliferation of erythroblastic and myeloblastic elements with atypical erythroblasts and myeloblasts in the peripheral blood. Di Guglielmo's Disease,Erythremic Myelosis,Erythroblastic Leukemia, Acute,Erythroleukemia,Leukemia, Myeloid, Acute, M6,Myeloid Leukemia, Acute, M6,Di Guglielmo Disease,Acute Erythroblastic Leukemia,Acute Erythroblastic Leukemias,Di Guglielmos Disease,Disease, Di Guglielmo,Disease, Di Guglielmo's,Erythremic Myeloses,Erythroblastic Leukemias, Acute,Erythroleukemias,Leukemia, Acute Erythroblastic,Leukemias, Acute Erythroblastic,Myeloses, Erythremic,Myelosis, Erythremic
D005472 Fluorouracil A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid. 5-FU,5-FU Lederle,5-FU Medac,5-Fluorouracil,5-Fluorouracil-Biosyn,5-HU Hexal,5FU,Adrucil,Carac,Efudex,Efudix,Fluoro-Uracile ICN,Fluoroplex,Fluorouracil Mononitrate,Fluorouracil Monopotassium Salt,Fluorouracil Monosodium Salt,Fluorouracil Potassium Salt,Fluorouracil-GRY,Fluorouracile Dakota,Fluorouracilo Ferrer Far,Fluoruracil,Fluracedyl,Flurodex,Haemato-FU,Neofluor,Onkofluor,Ribofluor,5 FU Lederle,5 FU Medac,5 Fluorouracil,5 Fluorouracil Biosyn,5 HU Hexal,Dakota, Fluorouracile,Fluoro Uracile ICN,Fluorouracil GRY,Haemato FU
D005978 Glutathione A tripeptide with many roles in cells. It conjugates to drugs to make them more soluble for excretion, is a cofactor for some enzymes, is involved in protein disulfide bond rearrangement and reduces peroxides. Reduced Glutathione,gamma-L-Glu-L-Cys-Gly,gamma-L-Glutamyl-L-Cysteinylglycine,Glutathione, Reduced,gamma L Glu L Cys Gly,gamma L Glutamyl L Cysteinylglycine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000903 Antibiotics, Antineoplastic Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. Antineoplastic Antibiotics,Cytotoxic Antibiotics,Antibiotics, Cytotoxic
D000964 Antimetabolites, Antineoplastic Antimetabolites that are useful in cancer chemotherapy. Antineoplastic Antimetabolites

Related Publications

Y Z Jin, and L Ding, and Z F Shen, and R M Cai, and L M Xu, and J K Yang, and X Q Jin, and W Q Lu, and J F Xu
Effects of glutathione depletion using buthionine sulphoximine on the cytotoxicity of nitroaromatic compounds in mammalian cells in vitro.
June 1985, Biochemical pharmacology,
Y Z Jin, and L Ding, and Z F Shen, and R M Cai, and L M Xu, and J K Yang, and X Q Jin, and W Q Lu, and J F Xu
Glutathione depletion and cytotoxicity of buthionine sulphoximine and SR2508 in rodent and human cells.
February 1990, International journal of radiation oncology, biology, physics,
Y Z Jin, and L Ding, and Z F Shen, and R M Cai, and L M Xu, and J K Yang, and X Q Jin, and W Q Lu, and J F Xu
The effects of buthionine sulphoximine (BSO) on glutathione depletion and xenobiotic biotransformation.
October 1984, Biochemical pharmacology,
Y Z Jin, and L Ding, and Z F Shen, and R M Cai, and L M Xu, and J K Yang, and X Q Jin, and W Q Lu, and J F Xu
Compartmentalised depletion of glutathione in cells treated with buthionine sulphoximine.
July 1987, The British journal of radiology,
Y Z Jin, and L Ding, and Z F Shen, and R M Cai, and L M Xu, and J K Yang, and X Q Jin, and W Q Lu, and J F Xu
Glutathione depletion in tissues after administration of buthionine sulphoximine.
August 1984, International journal of radiation oncology, biology, physics,
Y Z Jin, and L Ding, and Z F Shen, and R M Cai, and L M Xu, and J K Yang, and X Q Jin, and W Q Lu, and J F Xu
The effect of glutathione depletion by buthionine sulphoximine on 1-cyano-3,4-epithiobutane toxicity.
March 1991, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association,
Y Z Jin, and L Ding, and Z F Shen, and R M Cai, and L M Xu, and J K Yang, and X Q Jin, and W Q Lu, and J F Xu
Combined effect of misonidazole and glutathione depletion by buthionine sulphoximine on cellular radiation response.
April 1985, International journal of radiation biology and related studies in physics, chemistry, and medicine,
Y Z Jin, and L Ding, and Z F Shen, and R M Cai, and L M Xu, and J K Yang, and X Q Jin, and W Q Lu, and J F Xu
Modulation of the clastogenic activity of gamma-irradiation in buthionine sulphoximine-mediated glutathione depleted mammalian cells.
October 1999, International journal of radiation biology,
Y Z Jin, and L Ding, and Z F Shen, and R M Cai, and L M Xu, and J K Yang, and X Q Jin, and W Q Lu, and J F Xu
Effects on interstitial glutathione, cysteine and 5-S-cysteinyldopa of buthionine sulphoximine in human melanoma transplants.
August 1997, Melanoma research,
Y Z Jin, and L Ding, and Z F Shen, and R M Cai, and L M Xu, and J K Yang, and X Q Jin, and W Q Lu, and J F Xu
Enhanced melphalan cytotoxicity in human ovarian cancer in vitro and in tumor-bearing nude mice by buthionine sulfoximine depletion of glutathione.
January 1987, Biochemical pharmacology,
Copied contents to your clipboard!